---
title: "Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line"
collection: publications
permalink: /publication/2025-stemcells2
excerpt: 'Disease modeling using iPSC'
date: 2025-12-16
tags:
  - Lesch-Nyhan Disease
  - iPSC
  - Neurology
  - RNAseq
  - Emory Uiversity
venue: 'Stem Cells Translational Medicine'
paperurl: 'https://doi.org/10.1093/stcltm/szaf065'  
citation: '<i style="color:DodgerBlue;">Dinasarapu AR </i>, Sutcliffe DJ, Ozel E, Thite A, Grychowski L, Visser JE, Hess EJ, Kolk SM, Jinnah HA, Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line, Stem Cells Translational Medicine, 14, 12, 2025.'  
---  
Induced pluripotent stem cells (iPSCs) are commonly used to model human genetic diseases. Two main strategies are used. The first involves making iPSC lines from individual cases with a disease, and the second involves making disease-relevant gene edits in established iPSC lines. 
